Aqua Bio Technology ASA (OSL:ABTEC)
Norway · Delayed Price · Currency is NOK 0.7100
+0.0150 (2.16%)
At close: Sep 12, 2025
Aqua Bio Technology ASA Revenue
Aqua Bio Technology ASA had revenue of 7.72M NOK in the half year ending June 30, 2025, with 7.46% growth. This brings the company's revenue in the last twelve months to 102.75M, up 41.52% year-over-year. In the year 2024, Aqua Bio Technology ASA had annual revenue of 107.17M with 472.00% growth.
Revenue (ttm)
102.75M
Revenue Growth
+41.52%
P/S Ratio
0.75
Revenue / Employee
2.78M
Employees
37
Market Cap
77.28M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 107.17M | 88.44M | 472.00% |
| Dec 31, 2023 | 18.74M | 11.58M | 161.63% |
| Dec 31, 2022 | 7.16M | 5.19M | 262.49% |
| Dec 31, 2021 | 1.98M | 1.16M | 143.11% |
| Dec 31, 2020 | 812.63K | -482.56K | -37.26% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 628.08M |
| Nordhealth AS | 578.17M |
| Photocure ASA | 522.86M |
| ArcticZymes Technologies ASA | 104.33M |
| Vistin Pharma ASA | 452.25M |
| Omda AS | 458.96M |
| Gentian Diagnostics ASA | 163.38M |
| Lytix Biopharma AS | 608.00K |